303 related articles for article (PubMed ID: 23581830)
1. Treatment of bullous pemphigoid with low-dose oral cyclophosphamide: a case series of 20 patients.
Gual A; Iranzo P; Mascaró JM
J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):814-8. PubMed ID: 23581830
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive therapy for autoimmune bullous diseases.
Meurer M
Clin Dermatol; 2012; 30(1):78-83. PubMed ID: 22137230
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data.
Gürcan HM; Ahmed AR
Am J Clin Dermatol; 2009; 10(6):383-96. PubMed ID: 19824739
[TBL] [Abstract][Full Text] [Related]
4. Dual diagnosis of Pemphigus and pemphigoid. Retrospective review of thirty cases in the literature.
Sami N; Ahmed AR
Dermatology; 2001; 202(4):293-301. PubMed ID: 11455140
[TBL] [Abstract][Full Text] [Related]
5. [Dexamethasone-cyclophosphamide pulse therapy in bullous autoimmune dermatoses].
Appelhans M; Bonsmann G; Orge C; Bröcker EB
Hautarzt; 1993 Mar; 44(3):143-7. PubMed ID: 8463094
[TBL] [Abstract][Full Text] [Related]
6. Oral lesions in patients with pemphigus vulgaris and bullous pemphigoid.
Budimir J; Mihić LL; Situm M; Bulat V; Persić S; Tomljanović-Veselski M
Acta Clin Croat; 2008 Mar; 47(1):13-8. PubMed ID: 18714642
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of azathioprine and dapsone as an adjuvant in the treatment of bullous pemphigoid.
Tirado-Sánchez A; Díaz-Molina V; Ponce-Olivera RM
Allergol Immunopathol (Madr); 2012; 40(3):152-5. PubMed ID: 21497011
[TBL] [Abstract][Full Text] [Related]
8. [One year follow-up of patients with bullous pemphigoid].
Doffoel-Hantz V; Sparsa A; Marin B; Durox H; Bonnetblanc JM; Bédane C
Ann Dermatol Venereol; 2009 May; 136(5):407-11. PubMed ID: 19442795
[TBL] [Abstract][Full Text] [Related]
9. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
Gürcan HM; Ahmed AR
Ann Pharmacother; 2007 Oct; 41(10):1604-10. PubMed ID: 17785614
[TBL] [Abstract][Full Text] [Related]
10. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.
Joly P; Roujeau JC; Benichou J; Picard C; Dreno B; Delaporte E; Vaillant L; D'Incan M; Plantin P; Bedane C; Young P; Bernard P;
N Engl J Med; 2002 Jan; 346(5):321-7. PubMed ID: 11821508
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
Atzori L; Deidda S; Aste N
G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
Daoud YJ; Amin KG
Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of rituximab in a case of refractory bullous pemphigoid].
Reguiaï Z; Tchen T; Perceau G; Bernard P
Ann Dermatol Venereol; 2009 May; 136(5):431-4. PubMed ID: 19442800
[TBL] [Abstract][Full Text] [Related]
14. High-dose methylprednisolone in the treatment of bullous pemphigoid.
Siegel J; Eaglstein WH
Arch Dermatol; 1984 Sep; 120(9):1157-65. PubMed ID: 6383221
[TBL] [Abstract][Full Text] [Related]
15. Rituximab for treatment-refractory pemphigus and pemphigoid: a case series of 17 patients.
Kasperkiewicz M; Shimanovich I; Ludwig RJ; Rose C; Zillikens D; Schmidt E
J Am Acad Dermatol; 2011 Sep; 65(3):552-558. PubMed ID: 21641080
[TBL] [Abstract][Full Text] [Related]
16. Analysis of high-dose intravenous immunoglobulin therapy in 16 patients with refractory autoimmune blistering skin disease: high efficacy and no serious adverse events.
Seidling V; Hoffmann JH; Enk AH; Hadaschik EN
Acta Derm Venereol; 2013 May; 93(3):346-9. PubMed ID: 23073990
[TBL] [Abstract][Full Text] [Related]
17. A retrospective analysis of patients with bullous pemphigoid treated with methotrexate.
Kjellman P; Eriksson H; Berg P
Arch Dermatol; 2008 May; 144(5):612-6. PubMed ID: 18490587
[TBL] [Abstract][Full Text] [Related]
18. Low-dose methotrexate treatment in elderly patients with bullous pemphigoid.
Paul MA; Jorizzo JL; Fleischer AB; White WL
J Am Acad Dermatol; 1994 Oct; 31(4):620-5. PubMed ID: 8089289
[TBL] [Abstract][Full Text] [Related]
19. [Profile of bullous pemphigoid. A report of 47 cases].
Triki Ben Ammar S; Mokhtar I; Fazaa B; Kharfi M; Kamoun MR
Tunis Med; 2000 Oct; 78(10):584-8. PubMed ID: 11190743
[TBL] [Abstract][Full Text] [Related]
20. Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: A retrospective study with a 6-year follow-up.
Ahmed AR; Shetty S; Kaveri S; Spigelman ZS
J Am Acad Dermatol; 2016 Apr; 74(4):700-8.e3. PubMed ID: 26851830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
